Rachel H. McMahan, Ph.D.
Affiliations: | 2007 | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
ImmunologyGoogle:
"Rachel McMahan"Parents
Sign in to add mentor| Jill E. Slansky | grad student | 2007 | University of Colorado, Denver | |
| (Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Orlicky DJ, Libby AE, Bales ES, et al. (2018) Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions. The Journal of Physiology |
| Wang Y, Singh NK, Spear TT, et al. (2017) How an alloreactive T-cell receptor achieves peptide and MHC specificity. Proceedings of the National Academy of Sciences of the United States of America |
| Truong LD, Trostel J, McMahan R, et al. (2016) Macrophage A2A Adenosine Receptors Are Essential to Protect from Progressive Kidney Injury. The American Journal of Pathology |
| Spear TT, Riley TP, Lyons GE, et al. (2016) Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability. Journal of Leukocyte Biology |
| Golden-Mason L, McMahan RH, Strong M, et al. (2013) Galectin-9 functionally impairs natural killer cells in humans and mice. Journal of Virology. 87: 4835-45 |
| McMahan RH, Golden-Mason L, Nishimura MI, et al. (2010) Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. The Journal of Clinical Investigation. 120: 4546-57 |
| Mengshol JA, Golden-Mason L, Arikawa T, et al. (2010) A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. Plos One. 5: e9504 |
| Jordan KR, McMahan RH, Kemmler CB, et al. (2010) Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens. Proceedings of the National Academy of Sciences of the United States of America. 107: 4652-7 |
| McWilliams JA, Sullivan RT, Jordan KR, et al. (2008) Age-dependent tolerance to an endogenous tumor-associated antigen. Vaccine. 26: 1863-73 |
| Jordan KR, McMahan RH, Oh JZ, et al. (2008) Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 180: 188-97 |